Discovery of T cell epitopes implementing HLA-peptidomics into a reverse immunology approach

Journal of Immunology

Volumn 190, Issue 8, 2013, Pages 3869-3877

  Hombrink, Pleun ^a   Hassan, Chopie ^a   Kester, Michel G D ^a   De Ru, Arnoud H ^a   Van Bergen, Cornelis A M ^a   Nijveen, Harm ^b   Drijfhout, Jan W ^a   Frederik Falkenburg, J H ^a   Heemskerk, Mirjam H M ^a   Van Veelen, Peter A ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; EPITOPE; HLA CLASS I BINDING PEPTIDE; MINOR HISTOCOMPATIBILITY ANTIGEN; PEPTIDE; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; CELLULAR IMMUNITY; FEASIBILITY STUDY; HEMATOPOIETIC CELL; HLA SYSTEM; HUMAN; HUMAN CELL; IMMUNOLOGY; PEPTIDOMICS; PREDICTION; PRIORITY JOURNAL; T LYMPHOCYTE; TISSUE DISTRIBUTION;

B-LYMPHOCYTE SUBSETS; CELL LINE, TRANSFORMED; CELLS, CULTURED; COCULTURE TECHNIQUES; EPITOPES, T-LYMPHOCYTE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA-A2 ANTIGEN; HUMANS; MINOR HISTOCOMPATIBILITY ANTIGENS; PEPTIDES; PROTEIN BINDING; PROTEOMICS; T-LYMPHOCYTE SUBSETS;

EID: 84875970851     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1202351     Document Type: Article

References (44)

1. Porter, D. L., M. S. Roth, C. McGarigle, J. L. Ferrara, and J. H. Antin. 1994. Induction of graft-versus-host disease as immunotherapy for relapsed chronic myeloid leukemia. N. Engl. J. Med. 330: 100-106.
2. Kolb, H. J., A. Schattenberg, J. M. Goldman, B. Hertenstein, N. Jacobsen, W. Arcese, P. Ljungman, A. Ferrant, L. Verdonck, D. Niederwieser, et al; European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia. 1995. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. [see comments] Blood 86: 2041-2050.
3. Goulmy, E. 1997. Human minor histocompatibility antigens: new concepts for marrow transplantation and adoptive immunotherapy. Immunol. Rev. 157: 125-140.
4. Marijt, W. A. E., M. H. M. Heemskerk, F. M. Kloosterboer, E. Goulmy, M. G. D. Kester, M. A. W. G. van der Hoorn, S. A. P. van Luxemburg-Heys, M. Hoogeboom, T. Mutis, J. W. Drijfhout, et al. 2003. Hematopoiesis-restricted minor histocompatibility antigens HA-1-or HA-2-specific T cells can induce complete remissions of relapsed leukemia. Proc. Natl. Acad. Sci. USA 100: 2742-2747.
5. Falkenburg, J. H., L. van de Corput, E. W. Marijt, and R. Willemze. 2003. Minor histocompatibility antigens in human stem cell transplantation. Exp. Hematol. 31: 743-751.
6. de Bueger, M., A. Bakker, J. J. Van Rood, F. Van der Woude, and E. Goulmy. 1992. Tissue distribution of human minor histocompatibility antigens. Ubiquitous versus restricted tissue distribution indicates heterogeneity among human cytotoxic T lymphocyte-defined non-MHC antigens. J. Immunol. 149: 1788-1794.
7. Reddy, P., and J. L. M. Ferrara. 2003. Immunobiology of acute graft-versus-host disease. Blood Rev. 17: 187-194.
8. Ferrara, J. L., J. E. Levine, P. Reddy, and E. Holler. 2009. Graft-versus-host disease. Lancet 373: 1550-1561.
9. Warren, E. H., P. D. Greenberg, and S. R. Riddell. 1998. Cytotoxic T-lymphocyte-defined human minor histocompatibility antigens with a restricted tissue distribution. Blood 91: 2197-2207.
10. Dolstra, H., H. Fredrix, F. Maas, P. G. Coulie, F. Brasseur, E. Mensink, G. J. Adema, T. M. de Witte, C. G. Figdor, and E. van de Wiel-van Kemenade. 1999. A human minor histocompatibility antigen specific for B cell acute lym-phoblastic leukemia. J. Exp. Med. 189: 301-308.
11. Murata, M., E. H. Warren, and S. R. Riddell. 2003. A human minor histocom-patibility antigen resulting from differential expression due to a gene deletion. J. Exp. Med. 197: 1279-1289.
12. Slager, E. H., M. W. Honders, E. D. van der Meijden, S. A. P. van Luxemburg-Heijs, F. M. Kloosterboer, M. G. D. Kester, I. Jedema, W. A. E. Marijt, M. R. Schaafsma, R. Willemze, and J. H. F. Falkenburg. 2006. Identification of the angiogenic endothelial-cell growth factor-1/thymidine phosphorylase as a potential target for immunotherapy of cancer. Blood 107: 4954-4960.
13. Warren, E. H., B. E. Otterud, R. W. Linterman, A. G. Brickner, V. H. Engelhard, M. F. Leppert, P. J. Martin, and S. R. Riddell. 2002. Feasibility of using genetic linkage analysis to identify the genes encoding T cell-defined minor histocom-patibility antigens. Tissue Antigens 59: 293-303.
14. de Rijke, B., A. van Horssen-Zoetbrood, J. M. Beekman, B. Otterud, F. Maas, R. Woestenenk, M. Kester, M. Leppert, A. V. Schattenberg, T. de Witte, et al. 2005. A frameshift polymorphism in P2X5 elicits an allogeneic cytotoxic T lymphocyte response associated with remission of chronic myeloid leukemia. J. Clin. Invest. 115: 3506-3516.
15. Akatsuka, Y., T. Nishida, E. Kondo, M. Miyazaki, H. Taji, H. Iida, K. Tsujimura, M. Yazaki, T. Naoe, Y. Morishima, et al. 2003. Identification of a polymorphic gene, BCL2A1, encoding two novel hematopoietic lineage-specific minor his-tocompatibility antigens. J. Exp. Med. 197: 1489-1500.
16. van Bergen, C. A. M., M. G. D. Kester, I. Jedema, M. H. M. Heemskerk, S. A. P. van Luxemburg-Heijs, F. M. Kloosterboer, W. A. E. Marijt, A. H. de Ru, M. R. Schaafsma, R. Willemze, et al. 2007. Multiple myeloma-reactive T cells recognize an activation-induced minor histocompatibility antigen encoded by the ATP-dependent interferon-responsive (ADIR) gene. Blood 109: 4089-4096.
17. Rötzschke, O., K. Falk, H. J. Wallny, S. Faath, and H. G. Rammensee. 1990. Characterization of naturally occurring minor histocompatibility peptides including H-4 and H-Y. Science 249: 283-287.
18. den Haan, J. M., N. E. Sherman, E. Blokland, E. Huczko, F. Koning, J. W. Drijfhout, J. Skipper, J. Shabanowitz, D. F. Hunt, V. H. Engelhard, et al. 1995. Identification of a graft versus host disease-associated human minor his-tocompatibility antigen. Science 268: 1476-1480.
19. Spaapen, R. M., H. M. Lokhorst, K. van den Oudenalder, B. E. Otterud, H. Dolstra, M. F. Leppert, M. C. Minnema, A. C. Bloem, and T. Mutis. 2008. Toward targeting B cell cancers with CD4+ CTLs: identification of a CD19-encoded minor histocompatibility antigen using a novel genome-wide analysis. J. Exp. Med. 205: 2863-2872.
20. Kamei, M., Y. Nannya, H. Torikai, T. Kawase, K. Taura, Y. Inamoto, T. Takahashi, M. Yazaki, S. Morishima, K. Tsujimura, et al. 2009. HapMap scanning of novel human minor histocompatibility antigens. Blood 113: 5041-5048.
21. Kawase, T., Y. Nannya, H. Torikai, G. Yamamoto, M. Onizuka, S. Morishima, K. Tsujimura, K. Miyamura, Y. Kodera, Y. Morishima, et al. 2008. Identification of human minor histocompatibility antigens based on genetic association with highly parallel genotyping of pooled DNA. Blood 111: 3286-3294.
22. Celis, E., V. Tsai, C. Crimi, R. DeMars, P. A. Wentworth, R. W. Chesnut, H. M. Grey, A. Sette, and H. M. Serra. 1994. Induction of anti-tumor cytotoxic T lymphocytes in normal humans using primary cultures and synthetic peptide epitopes. Proc. Natl. Acad. Sci. USA 91: 2105-2109.
23. Maecker, B., von Bergwelt-Baildon, K. S. Anderson, R. H. Vonderheide, and J. L. Schultze. 2001. Linking genomics to immunotherapy by reverse immu-nology-'immunomics' in the new millennium. Curr. Mol. Med. 1: 609-619.
24. Van Der Bruggen, P., Y. Zhang, P. Chaux, V. Stroobant, C. Panichelli, E. S. Schultz, J. Chapiro, B. J. Van Den Eynde, F. Brasseur, and T. Boon. 2002. Tumor-specific shared antigenic peptides recognized by human T cells. Immunol. Rev. 188: 51-64.
25. Hombrink, P., S. R. Hadrup, A. Bakker, M. G. Kester, J. H. Falkenburg, P. A. von dem Borne, T. N. Schumacher, and M. H. Heemskerk. 2011. High-throughput identification of potential minor histocompatibility antigens by MHC tetramer-based screening: feasibility and limitations. PLoS ONE 6: e22523.
26. Ofran, Y., H. T. Kim, V. Brusic, L. Blake, M. Mandrell, C. J. Wu, S. Sarantopoulos, R. Bellucci, D. B. Keskin, R. J. Soiffer, et al. 2010. Diverse patterns of T-cell response against multiple newly identified human Y chromosome-encoded minor histocompatibility epitopes. Clin. Cancer Res. 16: 1642-1651.
27. Popovic, J., L. P. Li, P. M. Kloetzel, M. Leisegang, W. Uckert, and T. Blankenstein. 2011. The only proposed T-cell epitope derived from the TEL-AML1 translocation is not naturally processed. Blood 118: 946-954.
28. Hunt, D. F., R. A. Henderson, J. Shabanowitz, K. Sakaguchi, H. Michel, N. Sevilir, A. L. Cox, E. Appella, and V. H. Engelhard. 1992. Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry. Science 255: 1261-1263.
29. Falk, K., O. Rötzschke, S. Stevanović, G. Jung, and H. G. Rammensee. 1991. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 351: 290-296.
30. Admon, A., E. Barnea, and T. Ziv. 2003. Tumor antigens and proteomics from the point of view of the major histocompatibility complex peptides. Mol. Cell. Proteomics 2: 388-398.
31. Nijveen, H., M. G. Kester, C. Hassan, A. Viars, A. H. de Ru, M. de Jager, J. H. Falkenburg, J. A. Leunissen, and P. A. van Veelen. 2011. HSPVdb-the Human Short Peptide Variation Database for improved mass spectrometry-based detection of polymorphic HLA-ligands. Immunogenetics 63: 143-153.
32. Altman, J. D., P. A. H. Moss, P. J. R. Goulder, D. H. Barouch, M. G. McHeyzer-Williams, J. I. Bell, A. J. McMichael, and M. M. Davis. 1996. Phenotypic analysis of antigen-specific T lymphocytes. Science 274: 94-96.
33. Toebes, M., M. Coccoris, A. Bins, B. Rodenko, R. Gomez, N. J. Nieuwkoop, W. van de Kasteele, G. F. Rimmelzwaan, J. B. Haanen, H. Ovaa, and T. N. Schumacher. 2006. Design and use of conditional MHC class I ligands. Nat. Med. 12: 246-251.
34. Hadrup, S. R., A. H. Bakker, C. J. Shu, R. S. Andersen, J. van Veluw, P. Hombrink, E. Castermans, P. Thor Straten, C. Blank, J. B. Haanen, et al. 2009. Parallel detection of antigen-specific T-cell responses by multidimensional encoding of MHC multimers. Nat. Methods 6: 520-526.
35. Van Bergen, C. A., C. E. Rutten, E. D. Van Der Meijden, S. A. Van Luxemburg-Heijs, E. G. Lurvink, J. J. Houwing-Duistermaat, M. G. Kester, A. Mulder, R. Willemze, J. H. Falkenburg, and M. Griffioen. 2010. High-throughput characterization of 10 new minor histocompatibility antigens by whole genome association scanning. Cancer Res. 70: 9073-9083.
36. Burrows, S. R., N. Kienzle, A. Winterhalter, M. Bharadwaj, J. D. Altman, and A. Brooks. 2000. Peptide-MHC class I tetrameric complexes display exquisite ligand specificity. J. Immunol. 165: 6229-6234.
37. Rodenko, B., M. Toebes, S. R. Hadrup, W. J. van Esch, A. M. Molenaar, T. N. Schumacher, and H. Ovaa. 2006. Generation of peptide-MHC class I complexes through UV-mediated ligand exchange. Nat. Protoc. 1: 1120-1132.
38. Eijsink, C., M. G. Kester, M. E. Franke, K. L. Franken, M. H. Heemskerk, F. H. Claas, and A. Mulder. 2006. Rapid assessment of the antigenic integrity of tetrameric HLA complexes by human monoclonal HLA antibodies. J. Immunol. Methods 315: 153-161.
39. Stepniak, D., M. Wiesner, A. H. de Ru, A. K. Moustakas, J. W. Drijfhout, G. K. Papadopoulos, P. A. van Veelen, and F. Koning. 2008. Large-scale characterization of natural ligands explains the unique gluten-binding properties of HLA-DQ2. J. Immunol. 180: 3268-3278.
40. Pruitt, K. D., T. Tatusova, and D. R. Maglott. 2007. NCBI reference sequences (RefSeq): a curated non-redundant sequence database of genomes, transcripts and proteins. Nucleic Acids Res. 35(Database issue): D61-D65.
41. Hiemstra, H. S., G. Duinkerken, W. E. Benckhuijsen, R. Amons, R. R. de Vries, B. O. Roep, and J. W. Drijfhout. 1997. The identification of CD4+ T cell epi-topes with dedicated synthetic peptide libraries. Proc. Natl. Acad. Sci. USA 94: 10313-10318.
42. Smigielski, E. M., K. Sirotkin, M. Ward, and S. T. Sherry. 2000. dbSNP: a database of single nucleotide polymorphisms. Nucleic Acids Res. 28: 352-355.
43. Dolstra, H., B. de Rijke, H. Fredrix, A. Balas, F. Maas, F. Scherpen, M. J. Aviles, J. L. Vicario, N. J. Beekman, F. Ossendorp, et al. 2002. Bi-directional allelic recognition of the human minor histocompatibility antigen HB-1 by cytotoxic T lymphocytes. Eur. J. Immunol. 32: 2748-2758.
44. Wu, C., C. Orozco, J. Boyer, M. Leglise, J. Goodale, S. Batalov, C. L. Hodge, J. Haase, J. Janes, J. W. Huss, III, and A. I. Su. 2009. BioGPS: an extensible and customizable portal for querying and organizing gene annotation resources. Genome Biol. 10: R130.